Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Solid Tumors × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 10 Prostatic Neoplasms 9 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Fanconi Anemia, Complementation Group D1 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Carcinoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostate 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1

Interventions

tislelizumab 4 talazoparib 4 Docetaxel 4 PM 01183 2 Nivolumab 2 MLN 8237 2 Itraconazole 2 Fluorouracil 2 Cisplatin 2 Carboplatin 2 zimberelimab 1 ulixertinib 1 trifluridine tipiracil drug combination 1 sitravatinib 1 sapanisertib 1 pexidartinib 1 pevonedistat 1 peposertib 1 pembrolizumab 1 niraparib 1 mogamulizumab 1 lenvatinib 1 ixabepilone 1 eribulin 1 dalotuzumab 1 avelumab 1 ascrinvacumab 1 TLC 388 1 Rifampin 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡